it studied the use of statin simvastatin 40 mg medication and vitamin supplementation vitamin e vitamin c and beta carotene in patients who are at risk of cardiovascular disease it was led by jane armitage an epidemiologist at the clinical trial service unit an outline of the study protocol was published in 1999 initial results were published in 2002 which indicated that vitamins made little difference in modifying cardiovascular risk but that simvastatin could significantly reduce the risk of cardiovascular events further publications from 2003 and 2004 were concerned with the efficacy of simvastatin in diabetes patients and preventing stroke a 2005 paper analyses the cost effectiveness of a prescribing strategy similar to the one employed in the study the hps is to date the largest study to investigate the use of statins in the prevention of cardiovascular disease while there have been concerns about side effects associated with statins myopathy and rhabdomyolysis these were rare in this study the number needed to treat in the study was 57 patients to postpone one death and 19 to prevent one cardiovascular event in those taking the drug simvastatin for 5 years there was no mortality benefit in women with a statistical